During the past decade, Gastrointestinal Biosciences conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 6 clinical trials were completed, i.e. on average, 46.2% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gastrointestinal Biosciences" #1 sponsor was "Celgene" with 7 trials, followed by "Bristol-Myers Squibb" with 3 trials sponsored, "Millennium Pharmaceuticals, Inc." with 2 trials sponsored, "Conatus Pharmaceuticals Inc." with 1 trials sponsored and "Intercept Pharmaceuticals" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

According to Clinical.Site data, the most researched conditions in "Gastrointestinal Biosciences" are "Crohn Disease" (3 trials), "Eosinophilic Esophagitis" (3 trials), "Nonalcoholic Steatohepatitis" (3 trials), "Crohn's Disease" (2 trials) and "Liver Fibrosis" (2 trials). Many other conditions were trialed in "Gastrointestinal Biosciences" in a lesser frequency.

Most popular intervention types in "Gastrointestinal Biosciences" are "Drug" (16 trials) and "Other" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Ozanimod" (3 trials), "BMS-986036" (2 trials), "CC-93538" (2 trials) and "vedolizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Gastrointestinal Biosciences" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Gastrointestinal Biosciences". undefined are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Gastrointestinal Biosciences, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Gastrointestinal Biosciences, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".